Simple blood test could spot lung cancer early in heavy smokers

NCT ID NCT06816121

Recruiting now Diagnosis Sponsor: Everest Detection, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a new blood test to find early-stage lung cancer in heavy smokers who have no symptoms. Researchers will collect blood samples from 350 current or former smokers aged 30-80, including those with and without lung cancer. The goal is to see if the test can detect cancer early, when it's easier to treat. Participants give blood at the start and after 12 and 24 months, but results are not shared with them or their doctors.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: blood-based biomarker test
What this could lead to: If successful, this could lead to a simple blood test that catches lung cancer early in heavy smokers, when it's more treatable.
What could go wrong: This is an early observational study, not a treatment trial. The test may not be accurate enough, and results are not shared with participants or doctors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG CANCERS

Contacts and locations

Locations

Site 101
RECRUITING

Oklahoma City, Oklahoma, 73102, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.